News Sentiment

APLM sentiment intelligence

Apollomics Inc. Class A Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 18.52 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.3% over one week, +5.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Apollomics Inc. (APLM) appoints Hung-Hsien Yen to board

Market Reaction

Balanced read

59/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -2.3% Price reacting lower
Trend fit Trend inactive 5.8% over four weeks
Fair value -67.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 42
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 25
Market source 8
dars.gov.et 4
TradingView 4
Sahm 3
GlobeNewswire 2
simplywall.st 2
MarketBeat 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 13
Deals and strategy 5
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
Stock Titan Direct company coverage

Over 282 subjects enrolled as Apollomics targets 2027 U.S. filing

Apollomics (Nasdaq: APLM) reported full-year 2025 financial results, with revenue reaching $8.5 million and net loss narrowing to $10.9 million. The company is advancing the global development of its lead oncology asset, vebreltinib (APL-101), with over 282 subjects enrolled in t

Tone
Positive 73/100
Event
Earnings
Published
30 Apr 2026 02:39
Source
Stock Titan
Stock Titan Direct company coverage

APLM SEC Filings - APOLLOMICS INC 10-K, 10-Q, 8-K Forms

This page on Stock Titan provides a comprehensive resource for Apollomics Inc. (APLM) SEC filings, including annual reports (10-K, 20-F), quarterly earnings (10-Q), material events (8-K, 6-K), and insider trading forms. It offers direct access to regulatory disclosures as Apollom

Tone
Neutral 50/100
Event
Earnings
Published
24 Apr 2026 18:39
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) CFO has shares withheld for RSU tax obligations

Apollomics Inc.'s Chief Financial Officer, Peter Kuan-How Lin, had 3,582 Class A Ordinary Shares withheld to cover tax obligations at $15.85 per share upon the vesting of restricted stock units (RSUs). This was a routine tax-withholding event, not an open-market sale. Following t

Tone
Neutral 50/100
Event
Market update
Published
18 Apr 2026 13:39
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) director details RSUs, options and warrants in Form 3/A

Apollomics Inc. Director Hong-Jung Chen filed an amended initial ownership report (Form 3/A) detailing their current equity holdings in the company. The filing indicates Chen holds 1,000 restricted stock units vesting in two tranches in 2026, options for 2,290 Class A Ordinary Sh

Tone
Neutral 50/100
Event
Market update
Published
17 Apr 2026 23:09
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) director discloses 1,000 restricted stock units award

Apollomics Inc. director CHU YI-AN has reported an award of 1,000 restricted stock units (RSUs) in an amended Form 3/A filing. Each RSU represents a contingent right to receive one Class A Ordinary Share with a zero exercise price. The RSUs are scheduled to vest in two equal tran

Tone
Neutral 50/100
Event
Market update
Published
15 Apr 2026 00:09
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) director Huang Ya-Chi details RSU vesting and share holdings

Apollomics Inc. director Huang Ya-Chi has reported their equity holdings in the company, including 1,500 restricted stock units (RSUs) and 500 Class A Ordinary Shares. The RSUs are set to vest in three equal tranches throughout 2026, with an exercise price of $0.0000 per share. T

Tone
Neutral 50/100
Event
Market update
Published
15 Apr 2026 00:09
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) CFO details 20,000 RSUs and 15,900 shares in Form 3/A

Apollomics Inc.'s Chief Financial Officer, LIN PETER KUAN-HOW, filed an amended Form 3 detailing his equity holdings. The filing indicates he holds restricted stock units (RSUs) representing 20,000 Class A Ordinary Shares, which will vest in two equal tranches on June 15, 2026, a

Tone
Neutral 50/100
Event
Market update
Published
15 Apr 2026 00:09
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) director Jan Chen-Huan reports 1,000 RSUs and 1,000 shares

Apollomics Inc. director Jan Chen-Huan has filed an amended ownership report (Form 3/A) indicating holdings of 1,000 Restricted Stock Units (RSUs) and 1,000 Class A Ordinary Shares. The RSUs are set to vest in two equal installments of 500 shares each on June 15, 2026, and Septem

Tone
Neutral 50/100
Event
Market update
Published
15 Apr 2026 00:09
Source
Stock Titan
Stock Titan Direct company coverage

Apollomics (APLM) COO Yi-Kuei Chen discloses 5.3% ownership stake in latest filing

Apollomics Inc.'s Chief Operating Officer, Yi-Kuei (Alex) Chen, has reported a beneficial ownership stake of approximately 5.3% in the company's Class A ordinary shares. This ownership, totaling 115,171 shares, includes direct holdings, shares held through Maxpro Investment Co.,

Tone
Neutral 50/100
Event
Deals and strategy
Published
09 Apr 2026 10:39
Source
Stock Titan
TradingView Direct company coverage

Yi-Kuei Chen Discloses Investment at Apollomics Inc. with 5.3% Stake

Yi-Kuei (Alex) Chen, COO and director of Apollomics Inc., has disclosed a 5.3% beneficial stake in the company's Class A ordinary shares. This investment stems from vested and upcoming RSU grants and warrants, and Chen holds the shares for investment purposes, with no current pla

Tone
Positive 66/100
Event
Deals and strategy
Published
08 Apr 2026 22:39
Source
TradingView
Stock Titan Direct company coverage

Apollomics (APLM) chair reports 41.8% stake and $2M convertible bridge loan

Apollomics Inc. (APLM) chairman and CEO, Hung‑Wen (Howard) Chen, along with his entity King Regent Management Limited, now beneficially owns 41.8% of the company's Class A ordinary shares. Chen also provided Apollomics with an unsecured $2 million convertible promissory note as a

Tone
Neutral 50/100
Event
Deals and strategy
Published
06 Apr 2026 17:39
Source
Stock Titan
Sahm Direct company coverage

Apollomics Inc. Announces $2.0 Million Bridge Financing

Apollomics Inc. announced a $2.0 million unsecured Convertible Promissory Note with its Chairman and CEO, Mr. Hung-Wen (Howard) Chen, on March 30, 2026. The proceeds will fund clinical development and general operations. The note bears 0% interest and will convert into equity upo

Tone
Positive 64/100
Event
Market update
Published
05 Apr 2026 23:09
Source
Sahm
Stock Titan Direct company coverage

CEO funds Apollomics (Nasdaq: APLM) with $2M zero-interest convertible note

Apollomics Inc. (Nasdaq: APLM) has secured a $2 million zero-interest convertible promissory note from its Chairman and CEO, Hung-Wen Chen, for working capital and clinical development. This related-party transaction, approved by the independent Audit Committee and Board with Che

Tone
Neutral 50/100
Event
Market update
Published
01 Apr 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

APLMW SEC Filings - APOLLOMICS INC 10-K, 10-Q, 8-K Forms

This page provides a comprehensive overview of Apollomics Inc. (APLMW) SEC filings, including annual, quarterly, and material event reports, with AI-generated summaries for easier review. It details the company's focus on oncology therapies, financial situation, governance change

Tone
Negative 9/100
Event
Market update
Published
20 Mar 2026 02:39
Source
Stock Titan
Stock Titan Direct company coverage

Director in Apollomics (APLM) reports 2,000 restricted stock units on Form 3

Apollomics Inc. Director TSAI HSIEN-SHU has reported an initial holding of 2,000 restricted stock units (RSUs) on a Form 3 SEC filing. These RSUs are tied to Class A Ordinary Shares and vest over time, with 500 shares vesting upon grant on February 9, 2026, and subsequent 500-sha

Tone
Neutral 50/100
Event
Market update
Published
18 Mar 2026 22:38
Source
Stock Titan